Stay updated with breaking news from Sera Prognostics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A new study by the company titled ‘Preterm Birth Diagnostic Test Kits Market: Global Industry Analysis 2013-2022 and Opportunity Assessment 2022–2028’, has listed out the key points being considered by preterm birth diagnostic test kits companies to emerge and stay sustainably profitable in the long run in the prete...
Sera Prognostics (NASDAQ:SERA – Get Rating) and Viridian Therapeutics (NASDAQ:VRDN – Get Rating) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their institutional ownership, valuation, profitability, risk, dividends, earnings and analyst recommendations. Earnings & Valuation This table compares Sera Prognostics and […]
A new study by the company titled ‘Preterm Birth Diagnostic Test Kits Market: Global Industry Analysis 2013-2022 and Opportunity Assessment 2022–2028’, has listed out the key points being considered by preterm birth diagnostic test kits companies to emerge and stay sustainably profitable in the long run in the prete...
Sera Prognostics, Inc. (NASDAQ:SERA – Get Rating) saw a significant increase in short interest in the month of March. As of March 31st, there was short interest totalling 179,000 shares, an increase of 62.7% from the March 15th total of 110,000 shares. Based on an average daily trading volume, of 55,000 shares, the days-to-cover ratio […]
/PRNewswire/ -- Sera Prognostics Inc., The Pregnancy Company® (NASDAQ: SERA), focused on improving maternal and neonatal health by providing innovative...